Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Unknown 2Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 66Radiotherapy 52Carboplatin 25Bevacizumab 21Cisplatin 19Radiosurgery 18Vincristine 17Etoposide 17Cyclophosphamide 17Surgical Procedures, Operative 13Magnetic Resonance Spectroscopy 13Chemotherapy, Adjuvant 11Melphalan 10Lomustine 10Drug Therapy 10Filgrastim 9Erlotinib Hydrochloride 9apatinib 8Pemetrexed 83-Iodobenzylguanidine 8anlotinib 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Thiotepa 6Isotretinoin 6Irinotecan 6Ifosfamide 6Doxorubicin 6Carmustine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Perfusion Magnetic Resonance Imaging × CNS × Clear all
NCT02613988 2024-05-14

Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas

Asan Medical Center

Phase NA Unknown
100 enrolled
CNS

Glioblastoma

NCT05358340 2023-05-09

Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions

University Health Network, Toronto

Phase NA Unknown
100 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡